TY  - JOUR
AU  - Stojanović, Ivana D.
AU  - Dimitrijević, Mirjana
AU  - Vives-Pi, Marta
AU  - Mansilla, Maria Jose
AU  - Pujol-Autonell, Irma
AU  - Rodríguez-Fernandez, Silvia
AU  - Palova-Jelínkova, Lenka
AU  - Funda, David P.
AU  - Gruden-Movsesijan, Alisa
AU  - Sofronić-Milosavljević, Ljiljana
AU  - Hilkens, Catharien M. U.
AU  - Caceres, Eva Martinez
AU  - Miljković, Đorđe
PY  - 2017
UR  - http://www.eurekaselect.com/150098/article
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2819
AB  - Cell-based tolerogenic therapy is a promising approach for the treatment of autoimmune diseases and transplant rejection. Regulatory T cells and tolerogenic dendritic cells have been particularly explored in the treatment of various autoimmune disorders in experimental models of disease. Although some of these cells have already been tested in a limited number of clinical trials, there is still a need for preclinical research on tolerogenic cells in animal models of autoimmunity. This review will focus on the relevance of data obtained from studies in experimental animal models for the use of tolerogenic cell-based therapy in humans. Also, perspectives for further improvement of tolerogenic cell preparation towards enhanced suppressive activity and stability of the cells will be discussed.
T2  - Current Pharmaceutical Design
T1  - Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis
IS  - 18
VL  - 23
DO  - 10.2174/1381612823666170214120708
SP  - 2623
EP  - 2643
ER  - 

@article{
author = "Stojanović, Ivana D. and Dimitrijević, Mirjana and Vives-Pi, Marta and Mansilla, Maria Jose and Pujol-Autonell, Irma and Rodríguez-Fernandez, Silvia and Palova-Jelínkova, Lenka and Funda, David P. and Gruden-Movsesijan, Alisa and Sofronić-Milosavljević, Ljiljana and Hilkens, Catharien M. U. and Caceres, Eva Martinez and Miljković, Đorđe",
year = "2017",
abstract = "Cell-based tolerogenic therapy is a promising approach for the treatment of autoimmune diseases and transplant rejection. Regulatory T cells and tolerogenic dendritic cells have been particularly explored in the treatment of various autoimmune disorders in experimental models of disease. Although some of these cells have already been tested in a limited number of clinical trials, there is still a need for preclinical research on tolerogenic cells in animal models of autoimmunity. This review will focus on the relevance of data obtained from studies in experimental animal models for the use of tolerogenic cell-based therapy in humans. Also, perspectives for further improvement of tolerogenic cell preparation towards enhanced suppressive activity and stability of the cells will be discussed.",
journal = "Current Pharmaceutical Design",
title = "Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis",
number = "18",
volume = "23",
doi = "10.2174/1381612823666170214120708",
pages = "2623-2643"
}

Stojanović, I. D., Dimitrijević, M., Vives-Pi, M., Mansilla, M. J., Pujol-Autonell, I., Rodríguez-Fernandez, S., Palova-Jelínkova, L., Funda, D. P., Gruden-Movsesijan, A., Sofronić-Milosavljević, L., Hilkens, C. M. U., Caceres, E. M.,& Miljković, Đ.. (2017). Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis. in Current Pharmaceutical Design, 23(18), 2623-2643.
https://doi.org/10.2174/1381612823666170214120708

Stojanović ID, Dimitrijević M, Vives-Pi M, Mansilla MJ, Pujol-Autonell I, Rodríguez-Fernandez S, Palova-Jelínkova L, Funda DP, Gruden-Movsesijan A, Sofronić-Milosavljević L, Hilkens CMU, Caceres EM, Miljković Đ. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis. in Current Pharmaceutical Design. 2017;23(18):2623-2643.
doi:10.2174/1381612823666170214120708 .

Stojanović, Ivana D., Dimitrijević, Mirjana, Vives-Pi, Marta, Mansilla, Maria Jose, Pujol-Autonell, Irma, Rodríguez-Fernandez, Silvia, Palova-Jelínkova, Lenka, Funda, David P., Gruden-Movsesijan, Alisa, Sofronić-Milosavljević, Ljiljana, Hilkens, Catharien M. U., Caceres, Eva Martinez, Miljković, Đorđe, "Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis" in Current Pharmaceutical Design, 23, no. 18 (2017):2623-2643,
https://doi.org/10.2174/1381612823666170214120708 . .